Your session is about to expire
← Back to Search
Active intervention in Normal Ovulatory Women for Birth Control (OVULATION Trial)
OVULATION Trial Summary
This trial determines if medication taken 2 days before ovulation can delay ovulation by 7 days, and the side effects of the treatment vs control.
OVULATION Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OVULATION Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of heavy alcohol or marijuana use.Women who smoke more than 15 cigarettes per day or use more than 1 milliliter of nicotine-containing liquid for electronic cigarettes per day.You have a history of heart disease or stroke while pregnant or when using certain birth control methods.You are allergic to levonorgestrel or non-steroidal anti-inflammatory drugs (NSAIDs).You have an unknown vaginal discharge or any unusual sores or problems in the genital area. If you have a history of genital herpes, you can still participate if you don't have frequent outbreaks and are taking antiviral medication.You have a known allergy or reasons why you shouldn't take progestins.Your thyroid disorder is not under control.You have had other types of cancer, except for non-serious skin cancers, and you have been cancer-free for more than 5 years.You have unexplained or unusual bleeding from your genitals.You or someone in your family has a history of blood clotting issues.You have a history of headaches accompanied by specific problems with your brain or nerves.You have had stomach or intestinal ulcers or bleeding in the past.You have other types of liver tumors or currently have a liver disease.You have experienced yellowing of the skin during pregnancy or after using certain steroid hormones.You have a history of eye problems that affect the blood vessels or have experienced partial or complete vision loss.You have been diagnosed with or are suspected to have cancer in the breast, uterus, or other areas that are sensitive to progestin.You currently need to take hormones or blood thinning medication.
- Group 1: Placebo Comparator in Normal Ovulatory Women
- Group 2: Active intervention in Normal Ovulatory Women
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are the elderly being considered for participation in this clinical experiment?
"As set out in the study's criteria for participation, participants must be between 18 and 40 years old."
Has the FDA approved Active intervention in Normal Ovulatory Women yet?
"According to our team's assessment, the safety rating of Active intervention in Normal Ovulatory Women is 2. This refers to a Phase 2 trial, which has validating data on its security but not yet enough evidence for efficiency."
Is enrollment for this experiment currently open?
"Data available on clinicaltrials.gov reveals that this medical experiment is currently accepting participants. Initially posted on June 28th 2022, the trial has been amended as recently as January 12th 2023."
How frequently are individuals enrolling in this research project?
"That is correct. According to clinicaltrials.gov, this trial began on June 28th 2022 and has been actively recruiting since then. It requires 21 people across one site in order to complete the study's enrollment goals."
Am I eligible to partake in this research experiment?
"Only those within the age range of 18 and 40, who are taking appropriate contraceptive measures, can be considered for this study. A maximum of 21 patients will eventually be enrolled in the trial."
Share this study with friends
Copy Link
Messenger